UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

European Journal of Pharmacology

Volumn 449, Issue 1-2, 2002, Pages 99-103

  De Lago, Eva ^a   Fernández Ruiz, Javier ^a   Ortega Gutiérrez, Silvia ^a   Viso, Alma ^a   López Rodríguez, María Luz ^a   Ramos, José A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Endocannabinoid; UCM707; Uptake inhibition

Indexed keywords

ANANDAMIDE; ANTINOCICEPTIVE AGENT; CANNABINOID RECEPTOR ANTAGONIST; N (3 FURYLMETHYL)ARACHIDONAMIDE; UNCLASSIFIED DRUG; AMIDE; ANALGESIC AGENT; ARACHIDONIC ACID DERIVATIVE; CANNABINOID; ENDOCANNABINOID; FURAN DERIVATIVE; N-(3-FURYLMETHYL)EICOSA-5,8,11,14-TETRAENAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; EXPLORATORY BEHAVIOR; HEAT SENSITIVITY; MALE; MOBILIZATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; HEAT; METABOLISM; MOTOR ACTIVITY; PAIN ASSESSMENT; REACTION TIME; STEREOTYPY; WISTAR RAT;

ANALGESICS; ANIMAL; ARACHIDONIC ACIDS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXPLORATORY BEHAVIOR; FURANS; HEAT; MALE; MOTOR ACTIVITY; PAIN MEASUREMENT; RATS; RATS, WISTAR; REACTION TIME; STEREOTYPED BEHAVIOR; SUPPORT, NON-U.S. GOV'T; ANIMALS; ENDOCANNABINOIDS; POLYUNSATURATED ALKAMIDES;

EID: 0037008258     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01996-9     Document Type: Article

References (27)

1. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
2. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
3. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
4. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
5. Cannabinoid receptors and their endogenous agonists
6. Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the rat
7. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404
8. Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology
9. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
10. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
11. Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor
12. Endocannabinoids and vascular function
13. Pharmacology of cannabinoid receptors
14. Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors
15. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand
16. Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors
17. Endocannabinoid transporter inhibitors
18. Search for endogenous ligands of the cannabinoid receptors
19. Identification of an endogenous 2-monogliceride, present in canine gut, that binds to cannabinoid receptors
20. Presence and functional regulation of cannabinoid receptors in immune cells
21. 2 receptors
22. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
23. The endogenous cannabinoid system and the basal ganglia: Biochemical, pharmacological and therapeutic aspects
24. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
25. Cardiovascular actions of cannabinoids and their generation during shock
26. The neurobiology of cannabinoid analgesia
27. The anandamide transport inhibitor AM404 activates vanilloid receptors